查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929659

全球周邊自膨式支架市場（按產品類型、支架類型、材料、分銷管道和最終用戶分類）預測（2026-2032年）

Peripheral Vascular Self-Expanding Stent Market by Product Type, Stent Type, Material, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外周自動擴張型支架市場價值將達到 38.8 億美元，到 2026 年將成長至 41.7 億美元，到 2032 年將達到 61.4 億美元，複合年成長率為 6.78%。

關鍵市場統計數據
基準年 2025 38.8億美元
預計年份：2026年 41.7億美元
預測年份 2032 61.4億美元
複合年成長率 (%) 6.78%

自膨式周邊支架的策略性應用：一個闡述臨床優先事項、器材創新促進因素和採購要務的框架，這些因素共同塑造了支架的應用。

周邊自動擴張型支架的市場趨勢取決於臨床創新、不斷變化的監管要求以及供應鏈動態的轉變。臨床醫師持續尋求兼具徑向支撐動態和柔軟性的器械，以適應迂曲的血管解剖結構，最大限度地降低血管再阻塞風險，並提高長期通暢性。同時，採購人員和醫院管理者則關注醫療總成本、器械耐用性以及報銷和採購機制對資本和耗材預算的影響。

材料科學的創新、監管審查的加強、臨床實踐的演變以及供應鏈的韌性，將重新定義支架領域的競爭優勢。

周邊自動擴張型支架的競爭格局正受到多項變革性變化的影響，這些變化對產品開發和商業化策略具有重大意義。首先，隨著臨床實踐模式的演變，器械製造商正致力於提升器械的機械性能和輸送性能，因為針對特異性病變部位（尤其是在複雜的股膕動脈和膝下血管解剖結構中）的性能，相關證據也在不斷累積。其次，材料創新，特別是鎳鈦合金加工和塗層技術的進步，催生了新一代器械，這些器械具有更優異的徑向支撐力、抗疲勞性和生物相容性。

評估美國近期關稅調整如何影響支架價值鏈的籌資策略、採購行為和供應鏈韌性。

將於2025年生效的醫療設備原料和成品關稅政策，為製造商、經銷商和終端用戶帶來了新的商業性挑戰。某些醫療設備組件和成品支架的進口關稅提高，可能會增加依賴全球供應鏈的製造商的到岸成本，迫使許多公司重新評估其採購和製造地。為此，一些公司正在加快對本地供應商的資格認證流程，並評估在國內生產鎳鈦合金和鈷鉻合金等關鍵材料的可行性。

透過詳細的細分分析制定產品策略，將血管特異性動態、支架結構、終端用戶需求、分銷管道和材料權衡取捨結合起來。

對於產品團隊和商業負責人，明確細分市場至關重要，這有助於他們針對特定的臨床環境和採購情況最佳化產品供應、通訊和臨床證據產生。按血管部位進行區分仍然至關重要：股膕動脈介入器械需要兼顧柔軟性和支撐性，以適應股淺動脈和膕動脈；髂動脈介入器械則強調更大的直徑和長期徑向強度；脛動脈介入器械則優先考慮通過狹窄鈣化血管的輸送能力。認知到這些解剖學和動態差異有助於指導設計選擇和適應症指南。

區域策略觀點，整合美洲、歐洲、中東和非洲以及亞太市場不同的監管、採購和臨床實施模式

區域趨勢正以多種方式影響投資重點、監管策略和市場進入途徑。在美洲，手術量和完善的介入治療基礎設施持續推動著對那些能夠展現持續臨床療效和運作效率的醫療器材的需求。大型醫院網路和綜合醫療系統的採購架構強調全面的臨床證據和可預測的物流，而門診領域則為低複雜度周邊介入治療的拓展提供了契機。

醫療設備產業的競爭格局、合作夥伴關係和附加價值服務模式如何重塑企業策略和臨床偏好

產業相關人員正探索一個競爭加劇、創新目標明確、策略整合頻繁的環境。成熟的醫療技術公司持續投資於漸進式改進和產品組合最佳化，專注於透過材料改進和符合人體工學的輸送系統設計來實現設備差異化。同時，小規模的專業開發商正利用新型塗層技術、混合設計和有針對性的臨床合作，在複雜的病理領域中建立起獨特的市場地位。

為經營團隊提供切實可行的策略建議，以協調創新、供應鏈韌性和商業性可行性與不斷變化的臨床和採購優先事項。

尋求獲得永續競爭優勢的領導者應推行一系列合作舉措，協調研發、監管、供應鏈和商業職能。首先，應優先投資於材料和設計，以應對特定的解剖學挑戰，例如提高股膕窩區域的貼合度以及在長病變部位保持抗疲勞性。這種技術重點應與綜合循證醫學計劃相結合，該計劃強調真實世界結果和註冊登記參與，以增強長期臨床可靠性。

一種透明的、三角驗證的調查方法，結合了臨床訪談、監管審查和供應鏈情境分析，以指導策略決策。

本綜述的研究結合了定性和定量資訊，旨在全面了解影響自動擴張型支架的臨床、商業性和供應鏈因素。主要資訊來源包括對介入醫師、採購主管和分銷合作夥伴的結構化訪談，以及產品標籤、監管文件和已發表的臨床研究。這些工作提供了不同醫療機構的手術流程、最終用戶偏好和競標機制的背景資訊。

一份簡潔、全面的分析報告，重點在於臨床證據、材料創新、供應鏈韌性和商業性敏捷性這四者之間的交集，這些因素將決定企業的長期成功。

總之，外周自動擴張型支架的生態系統在臨床證據日趨成熟、材料創新、監管審查日益嚴格以及商業性格局變化等多重因素的共同影響下持續發展。能夠滿足特定血管區域動態要求、擁有可靠的真實世界數據支援並符合終端用戶工作流程的器械最有可能獲得持續的臨床應用。同時，供應鏈的韌性和靈活的商業模式對於應對關稅壓力和採購流程的複雜性至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊自膨式支架市場（依產品類型分類）

  • 裸金屬自動擴張型支架
  • 藥物釋放型自擴張支架
    • 抗增殖藥物釋放型支架
    • 抗發炎藥物洗脫支架
    • 複方藥物釋放型支架
  • 覆膜自膨式血管支架
    • 全覆膜血管支架
    • 部分覆膜血管支架
  • 生物可吸收自膨脹支架
  • 模組化或分段式自膨式支架

9. 周邊血管自膨式支架市場（依支架類型分類）

  • 裸金屬支架
  • 覆蓋類型
  • 藥物釋放型型

10. 周邊自膨式支架市場（依材料分類）

  • 鎳鈦諾合金
  • 鈷鉻合金
  • 不銹鋼合金
  • 聚合物基材料
    • 完全生物可吸收聚合物
    • 不可吸收聚合物
  • 複合材料
    • 金屬-聚合物複合材料
    • 金屬複合材料

11. 外周自膨式支架市場（依分銷通路分類）

  • 直接競標
  • 分銷商銷售

12. 外周自膨式支架市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 血管診所

13. 外周自膨式支架市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

14. 周邊自膨式支架市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國外周自膨式支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國周邊自膨式支架市場

第17章：中國周邊血管自膨式支架市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • InspireMD, Inc.
  • iVascular SLU
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • Terumo Corporation
  • Translumina GmbH
  • WL Gore & Associates, Inc.
Product Code: MRR-0A3806951876

The Peripheral Vascular Self-Expanding Stent Market was valued at USD 3.88 billion in 2025 and is projected to grow to USD 4.17 billion in 2026, with a CAGR of 6.78%, reaching USD 6.14 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.88 billion
Estimated Year [2026] USD 4.17 billion
Forecast Year [2032] USD 6.14 billion
CAGR (%) 6.78%

A strategic introduction to self-expanding peripheral stents that frames clinical priorities, device innovation drivers, and procurement imperatives shaping adoption

The peripheral vascular self-expanding stent landscape sits at the intersection of clinical innovation, evolving regulatory expectations, and shifting supply chain dynamics. Clinicians continue to seek devices that balance radial strength with conformability to tortuous anatomy while minimizing the risk of restenosis and improving long-term patency. At the same time, procurement leaders and hospital administrators are focused on total cost of care, device durability, and the implications of reimbursement and purchasing frameworks for capital and consumable budgets.

Consequently, device developers are concentrating on materials science and design refinements that optimize delivery profiles and lesion coverage without compromising deployment control. Parallel advances in adjunctive therapies, imaging guidance, and hybrid procedural workflows are changing how interventional teams evaluate candidates for self-expanding stents versus alternative therapies. In this context, strategic clarity around vessel-specific performance, material tradeoffs, and end-user requirements is increasingly essential for product development and market positioning.

As stakeholders assess near-term tactical choices and longer-term strategic roadmaps, the ability to synthesize clinical evidence, operational constraints, and supply considerations will determine who captures clinical preference and procurement momentum in a competitive and regulated environment.

How material science breakthroughs, regulatory vigilance, clinical practice evolution, and supply chain resilience are redefining competitive advantage in the stent arena

The competitive terrain for peripheral self-expanding stents is being reshaped by several transformative shifts that have material implications for product development and commercialization strategies. First, clinical practice patterns are evolving as evidence accumulates regarding lesion-specific performance, particularly in complex femoropopliteal and below-the-knee anatomies, prompting device makers to refine mechanical profiles and deliverability. Second, materials innovation-especially advances in nitinol processing and coatings-has enabled a new generation of devices that address radial force, fatigue resistance, and biocompatibility in more nuanced ways.

Concurrently, regulatory pathways and post-market surveillance expectations are tightening, emphasizing real-world evidence and long-term follow-up. This has encouraged manufacturers to integrate data generation into launch plans and to partner more closely with clinical networks. Moreover, supply chain strategies are shifting towards resilience, with firms diversifying sourcing and considering near-shoring to mitigate disruption risks. Finally, distribution models are adapting as ambulatory surgery centers expand their role in peripheral interventions and as tender processes and distributor relationships evolve, affecting how market access teams prioritize channels.

Taken together, these changes compel a holistic reassessment of product roadmaps, clinical engagement strategies, and commercial models to maintain competitive differentiation and ensure alignment with emerging provider and payer expectations.

Assessing how recent tariff shifts in the United States have reshaped sourcing strategies, procurement behavior, and supply chain resilience across the stent value chain

The introduction of tariff measures affecting medical device inputs and finished goods in 2025 has introduced a new layer of commercial complexity for manufacturers, distributors, and end users. Increased import duties on certain medical device components and finished stents can raise landed costs for manufacturers that rely on global supply chains, prompting many to reassess procurement and manufacturing footprints. In response, a number of firms have accelerated vendor qualification processes for local suppliers and evaluated the feasibility of domestic fabrication for critical materials such as nickel-titanium alloys and cobalt chromium.

At the provider level, purchasing teams and group purchasing organizations are responding to cost pressures by tightening tender requirements, elongating contract negotiation cycles, and seeking greater transparency around component origin and total landed cost. In addition, hospitals and ambulatory surgery centers are increasingly prioritizing vendor consolidation and value agreements that incorporate clinical outcomes, warranty provisions, and bundled pricing constructs. These procurement behaviors are likely to influence which products remain commercially viable within specific institutional formularies.

Importantly, the tariff environment also reinforces the strategic value of supply chain diversification and manufacturing flexibility. To mitigate the impact of duties, companies have been exploring dual-sourcing strategies, multi-regional inventory planning, and investments in manufacturing process automation that can offset incremental cost pressures. While tariffs introduce operational headwinds, they also create an impetus for greater transparency across the value chain and for closer collaboration between commercial, regulatory, and supply chain functions to preserve access and competitiveness.

Detailed segmentation insights that align vessel-specific biomechanics, stent architecture, end-user needs, distribution channels, and material tradeoffs to inform product strategy

Segment-level clarity is essential for product teams and commercial strategists to tailor offerings, messaging, and clinical evidence generation to specific clinical and purchasing contexts. Vessel-site differentiation remains fundamental: devices intended for the femoropopliteal territory require a balance between flexibility and support to accommodate the superficial femoral artery and the popliteal artery, while iliac applications emphasize larger diameters and long-term radial strength, and tibial interventions prioritize deliverability through small, calcified vessels. Recognizing these anatomic and biomechanical distinctions guides design choices and label claims.

Product architecture and clinical positioning are further influenced by stent type. Bare metal options continue to be relevant where durability and cost considerations predominate, covered designs offer advantages in cases where seal and exclusion of aneurysmal segments are priorities, and drug-eluting platforms are being evaluated for their potential to reduce neointimal proliferation and improve patency in restenosis-prone lesions. End-user environments shape commercial approaches as well; hospitals and vascular specialty clinics often demand comprehensive clinical data, robust inventory management, and integrated training programs, whereas ambulatory surgery centers may prioritize streamlined delivery systems, predictable procedure times, and favorable economics.

Distribution channels and material selection also interact with commercialization choices. Direct tender relationships remain critical for large institutional buyers seeking price and service commitments, while distributor sales channels provide reach in fragmented markets and support for smaller facilities. Material selection-whether cobalt chromium for high radial strength, nitinol for superior superelasticity, or stainless steel where cost and proven performance are deciding factors-affects manufacturing complexity, regulatory pathways, and marketing narratives. Consequently, nuanced segmentation that weaves anatomic need, device type, end-user demands, channel strategy, and material attributes is indispensable for targeted market entry and lifecycle management.

Regional strategic perspectives that reconcile diverse regulatory, procurement, and clinical adoption patterns across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics are shaping investment priorities, regulatory strategies, and market access pathways across multiple fronts. In the Americas, procedural volumes and established interventional infrastructures continue to drive demand for devices that demonstrate durable clinical outcomes and operational efficiencies. Procurement frameworks in large hospital networks and integrated delivery systems place a premium on comprehensive clinical evidence and predictable logistics, while the ambulatory care sector offers an expanding venue for lower-complexity peripheral interventions.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and heterogeneous reimbursement environments necessitate adaptable market access plans that reflect country-level variations. In some European markets, strong national registries and tendering mechanisms require proactive engagement and the ability to supply robust long-term efficacy data. In parts of the Middle East and Africa, investments in specialist vascular centers and public procurement programs are creating pockets of rapid device adoption, albeit accompanied by complex importation and distribution considerations.

The Asia-Pacific region presents a blend of mature markets with stringent regulatory pathways and emerging markets with accelerating investment in interventional cardiology and peripheral vascular services. Manufacturers often pursue differentiated go-to-market approaches here, combining strategic partnerships, localized clinical studies, and flexible distribution agreements to address variable infrastructure and reimbursement maturity. Overall, regional strategy must balance global product integrity with localized evidence generation, tailored commercial models, and supply chain adaptability to meet diverse clinical and procurement realities.

How competitive dynamics, collaborative partnerships, and value-added service models are reshaping corporate strategies and clinical preference formation in the device sector

Industry participants are navigating a landscape characterized by intensified competition, targeted innovation, and strategic consolidation. Established medtech firms continue to invest in incremental improvements and portfolio optimization, focusing on device differentiation through material enhancements and delivery system ergonomics. Simultaneously, smaller specialized developers are leveraging novel coatings, hybrid designs, and targeted clinical collaborations to carve out niche positions in complex lesion segments.

Partnerships between device manufacturers and hospital systems, research consortia, and contract manufacturers are increasingly common, enabling access to clinical networks, manufacturing scale, and complementary expertise. These collaborative arrangements facilitate faster evidence generation and more resilient supply chains, which are particularly valuable in environments where regional regulatory and procurement requirements vary. Investors and strategic acquirers are also evaluating technology roadmaps and clinic-commercial synergies when assessing opportunities for consolidation or minority stakes.

Service offerings beyond the product itself-such as training programs, digital procedural support, and post-market evidence packages-are becoming differentiators in tender evaluations and clinician preference. Consequently, companies that integrate clinical education, robust warranty and returns policies, and clear value narratives into their commercial execution are better positioned to influence hospital formulary decisions and physician adoption patterns.

Actionable strategic recommendations for executives to align innovation, supply chain resilience, and commercial execution with evolving clinical and procurement priorities

Leaders seeking to secure sustainable advantage should pursue a coordinated set of actions that align R&D, regulatory, supply chain, and commercial functions. First, prioritize material and design investments that address specific anatomic challenges, such as enhancing conformability for the femoropopliteal corridor while maintaining fatigue resistance for long lesions. This technical focus should be paired with an integrated evidence plan that emphasizes real-world outcomes and registry participation to strengthen clinical credibility over time.

Second, bolster supply chain resilience by qualifying alternative suppliers for critical inputs, evaluating regional manufacturing options to mitigate tariff exposure, and deploying inventory strategies that balance cost and service levels. At the same time, refine commercial models to reflect end-user heterogeneity: tailor propositions for ambulatory surgery centers around procedural efficiency and device simplicity, while offering comprehensive training and clinical support to hospitals and specialty clinics.

Third, leverage value-based contracting and outcome-linked arrangements where feasible to align commercial incentives with provider priorities. Complement these approaches with targeted investments in training, digital procedural guidance, and post-market surveillance to create defensible differentiation. Finally, cultivate strategic partnerships with clinical networks and payers to expedite adoption, ensure coverage alignment, and generate the longitudinal data necessary to sustain long-term clinical trust.

A transparent, triangulated research methodology combining clinical interviews, regulatory review, and supply chain scenario analysis to inform strategic decision making

The research underpinning this summary integrates qualitative and quantitative inputs to build a nuanced understanding of clinical, commercial, and supply chain factors affecting self-expanding stents. Primary inputs included structured interviews with interventional specialists, procurement leaders, and distribution partners, complemented by device labeling, regulatory filings, and published clinical studies. These engagements provided contextual insights into procedural workflows, end-user preferences, and tender mechanics across a range of healthcare settings.

Secondary inputs comprised peer-reviewed literature, device registries, and regulatory guidance documents to contextualize safety and performance considerations. The analysis employed cross-segment mapping to relate design attributes-such as material choice and stent architecture-to clinical application and end-user requirements. In addition, scenario analysis explored the operational implications of supply chain shocks and tariff changes, identifying practical mitigation strategies without projecting specific numeric outcomes.

Throughout the methodology, emphasis was placed on triangulation to validate findings and minimize bias. This approach ensured that strategic recommendations reflect a synthesis of clinical perspectives, procurement realities, and manufacturing considerations, thereby supporting actionable decision making for product development, market access, and commercial execution.

A concise synthesis highlighting the intersection of clinical evidence, materials innovation, supply chain resilience, and commercial agility that will determine long-term success

In summary, the peripheral vascular self-expanding stent ecosystem is evolving under the combined influence of clinical evidence maturation, materials innovation, regulatory scrutiny, and shifting commercial dynamics. Devices tailored to the biomechanical demands of specific vessel territories, supported by robust real-world data and aligned with end-user workflows, are most likely to achieve durable clinical adoption. At the same time, supply chain resilience and adaptable commercial models are essential to navigate tariff pressures and procurement complexities.

Looking forward, organizations that integrate targeted engineering advances with proactive evidence generation and flexible manufacturing will be best positioned to meet differentiated clinical needs while maintaining competitive cost structures. Coordinated engagement across clinical, regulatory, and commercial teams will accelerate market access and help establish long-term relationships with health systems, ambulatory centers, and specialty clinics. Ultimately, strategic clarity on segmentation, regional approach, and partnership models will determine which firms capture clinician preference and procurement momentum in a dynamic and increasingly outcome-driven environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Self-Expanding Stent Market, by Product Type

  • 8.1. Bare Metal Self-Expanding Stents
  • 8.2. Drug-Eluting Self-Expanding Stents
    • 8.2.1. Antiproliferative Drug-Eluting Stents
    • 8.2.2. Anti-Inflammatory Drug-Eluting Stents
    • 8.2.3. Combination Drug-Eluting Stents
  • 8.3. Covered Self-Expanding Stent Grafts
    • 8.3.1. Full-Covered Stent Grafts
    • 8.3.2. Partial-Covered Stent Grafts
  • 8.4. Bioresorbable Self-Expanding Scaffolds
  • 8.5. Modular Or Segmental Self-Expanding Stents

9. Peripheral Vascular Self-Expanding Stent Market, by Stent Type

  • 9.1. Bare Metal
  • 9.2. Covered
  • 9.3. Drug Eluting

10. Peripheral Vascular Self-Expanding Stent Market, by Material

  • 10.1. Nitinol Alloys
  • 10.2. Cobalt-Chromium Alloys
  • 10.3. Stainless Steel Alloys
  • 10.4. Polymer-Based Materials
    • 10.4.1. Fully Bioresorbable Polymers
    • 10.4.2. Non-Resorbable Polymers
  • 10.5. Composite Materials
    • 10.5.1. Metal-Polymer Composites
    • 10.5.2. Metal-Matrix Composites

11. Peripheral Vascular Self-Expanding Stent Market, by Distribution Channel

  • 11.1. Direct Tender
  • 11.2. Distributor Sales

12. Peripheral Vascular Self-Expanding Stent Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
  • 12.3. Vascular Specialty Clinics

13. Peripheral Vascular Self-Expanding Stent Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral Vascular Self-Expanding Stent Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral Vascular Self-Expanding Stent Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral Vascular Self-Expanding Stent Market

17. China Peripheral Vascular Self-Expanding Stent Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. B. Braun Melsungen AG
  • 18.7. BIOTRONIK SE & Co. KG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cook Medical Inc.
  • 18.10. Cordis Corporation
  • 18.11. Endologix, Inc.
  • 18.12. InspireMD, Inc.
  • 18.13. iVascular SLU
  • 18.14. Lepu Medical Technology Co., Ltd.
  • 18.15. Medtronic plc
  • 18.16. Meril Life Sciences Pvt. Ltd.
  • 18.17. MicroPort Scientific Corporation
  • 18.18. Stryker Corporation
  • 18.19. Terumo Corporation
  • 18.20. Translumina GmbH
  • 18.21. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BARE METAL SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BARE METAL SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BARE METAL SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY ANTIPROLIFERATIVE DRUG-ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY ANTIPROLIFERATIVE DRUG-ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY ANTIPROLIFERATIVE DRUG-ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUG-ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUG-ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUG-ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMBINATION DRUG-ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMBINATION DRUG-ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMBINATION DRUG-ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY FULL-COVERED STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY FULL-COVERED STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY FULL-COVERED STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PARTIAL-COVERED STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PARTIAL-COVERED STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PARTIAL-COVERED STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BIORESORBABLE SELF-EXPANDING SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BIORESORBABLE SELF-EXPANDING SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BIORESORBABLE SELF-EXPANDING SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MODULAR OR SEGMENTAL SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MODULAR OR SEGMENTAL SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MODULAR OR SEGMENTAL SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY NITINOL ALLOYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY NITINOL ALLOYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY NITINOL ALLOYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COBALT-CHROMIUM ALLOYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COBALT-CHROMIUM ALLOYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COBALT-CHROMIUM ALLOYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STAINLESS STEEL ALLOYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STAINLESS STEEL ALLOYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STAINLESS STEEL ALLOYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY FULLY BIORESORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY FULLY BIORESORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY FULLY BIORESORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY NON-RESORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY NON-RESORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY NON-RESORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY METAL-POLYMER COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY METAL-POLYMER COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY METAL-POLYMER COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY METAL-MATRIX COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY METAL-MATRIX COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY METAL-MATRIX COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY VASCULAR SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY VASCULAR SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY VASCULAR SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 220. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. G7 PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 228. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 230. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. NATO PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DRUG-ELUTING SELF-EXPANDING STENTS, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COVERED SELF-EXPANDING STENT GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY POLYMER-BASED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA PERIPHERAL VASCULAR SELF-EXPANDING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)